Literature DB >> 22367796

The neurotrophin family of neurotrophic factors: an overview.

Stephen D Skaper1.   

Abstract

The neurotrophins are a family of closely related proteins that were first identified as survival factors for sympathetic and sensory neurons and have since been shown to control a number of aspects of survival, development, and function of neurons in both the central and peripheral nervous systems. Limiting quantities of neurotrophins during development control the numbers of surviving neurons to ensure a match between neurons and the requirement for a suitable density of target innervation. Biological effects of each of the four mammalian neurotrophins are mediated through activation of one or more of the three members of the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB, and TrkC). In addition, all neurotrophins activate the p75 neurotrophin receptor, a member of the tumor necrosis factor receptor superfamily. Neurotrophin engagement of Trk receptors leads to activation of Ras, phosphatidylinositol 3-kinase, phospholipase C-γ1, and signaling pathways controlled through these proteins, including the mitogen-activated protein kinases. Neurotrophin availability is required into adulthood, where they control synaptic function and plasticity and sustain neuronal cell survival, morphology, and differentiation. This chapter will provide an overview of neurotrophin biology, their receptors, and signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367796     DOI: 10.1007/978-1-61779-536-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  118 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

Review 2.  The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease.

Authors:  Josiane Budni; Tatiani Bellettini-Santos; Francielle Mina; Michelle Lima Garcez; Alexandra Ioppi Zugno
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 3.  Therapeutic targets for neuroblastomas.

Authors:  Garrett M Brodeur; Radhika Iyer; Jamie L Croucher; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

4.  TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.

Authors:  Ezra Y Rosen; Debra A Goldman; Jaclyn F Hechtman; Ryma Benayed; Alison M Schram; Emiliano Cocco; Sophie Shifman; Yixiao Gong; Ritika Kundra; James P Solomon; Alberto Bardelli; Maurizio Scaltriti; Alexander Drilon; Alexia Iasonos; Barry S Taylor; David M Hyman
Journal:  Clin Cancer Res       Date:  2019-12-23       Impact factor: 12.531

5.  Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer.

Authors:  Jay Pundavela; Severine Roselli; Sam Faulkner; John Attia; Rodney J Scott; Rick F Thorne; John F Forbes; Ralph A Bradshaw; Marjorie M Walker; Phillip Jobling; Hubert Hondermarck
Journal:  Mol Oncol       Date:  2015-05-14       Impact factor: 6.603

6.  Synthetic inhibitor leads of human tropomyosin receptor kinase A (hTrkA).

Authors:  Govindan Subramanian; Rajendran Vairagoundar; Scott J Bowen; Nicole Roush; Theresa Zachary; Christopher Javens; Tracey Williams; Ann Janssen; Andrea Gonzales
Journal:  RSC Med Chem       Date:  2020-01-10

7.  The Effects of Voluntary Physical Exercise-Activated Neurotrophic Signaling in Rat Hippocampus on mRNA Levels of Downstream Signaling Molecules.

Authors:  Christina A E Solvsten; Tina F Daugaard; Yonglun Luo; Frank de Paoli; Jane H Christensen; Anders L Nielsen
Journal:  J Mol Neurosci       Date:  2017-04-24       Impact factor: 3.444

8.  Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia.

Authors:  Fei Ye; Qiongqiong Zhan; Wenhuan Xiao; Weiwei Sha; Xiaobin Zhang
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

9.  Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model.

Authors:  Mathieu Blais; Philippe Lévesque; Sabrina Bellenfant; François Berthod
Journal:  Tissue Eng Part A       Date:  2013-03-26       Impact factor: 3.845

Review 10.  Neurotrophic Factors and Their Potential Applications in Tissue Regeneration.

Authors:  Nan Xiao; Quynh-Thu Le
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-11-26       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.